Identification of Some Glutamic Acid Derivatives with Biological Potential by Computational Methods

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 May 27

PMID 37241864

Authors

Octavia-Laura Moldovan

Alexandra Sandulea

Ioana-Andreea Lungu

Serban Andrei Gaz

Aura Rusu

Affiliations

Soon will be listed here.

Abstract

Glutamic acid is a non-essential amino acid involved in multiple metabolic pathways. Of high importance is its relationship with glutamine, an essential fuel for cancer cell development. Compounds that can modify glutamine or glutamic acid behaviour in cancer cells have resulted in attractive anticancer therapeutic alternatives. Based on this idea, we theoretically formulated 123 glutamic acid derivatives using Biovia Draw. Suitable candidates for our research were selected among them. For this, online platforms and programs were used to describe specific properties and their behaviour in the human organism. Nine compounds proved to have suitable or easy to optimise properties. The selected compounds showed cytotoxicity against breast adenocarcinoma, lung cancer cell lines, colon carcinoma, and T cells from acute leukaemia. Compound 2Ba5 exhibited the lowest toxicity, and derivative 4Db6 exhibited the most intense bioactivity. Molecular docking studies were also performed. The binding site of the 4Db6 compound in the glutamine synthetase structure was determined, with the D subunit and cluster 1 being the most promising. In conclusion, glutamic acid is an amino acid that can be manipulated very easily. Therefore, molecules derived from its structure have great potential to become innovative drugs, and further research on these will be conducted.

Citing Articles

In Silico Evaluation of Some Computer-Designed Fluoroquinolone-Glutamic Acid Hybrids as Potential Topoisomerase II Inhibitors with Anti-Cancer Effect.

Oancea O, Gaz S, Marc G, Lungu I, Rusu A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770435 PMC: 11679884. DOI: 10.3390/ph17121593.

Elucidating Chiral Resolution of Aromatic Amino Acids Using Glycopeptide Selectors: A Combined Molecular Docking and Chromatographic Study.

Gherdaoui D, Yahoum M, Toumi S, Lekmine S, Lefnaoui S, Benslama O Int J Mol Sci. 2024; 25(16).

PMID: 39201804 PMC: 11354492. DOI: 10.3390/ijms25169120.

References

Wasfy R, Eldeen A . Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions. Asian Pac J Cancer Prev. 2015; 16(11):4769-75. DOI: 10.7314/apjcp.2015.16.11.4769. View

Kawanishi S, Yamamoto K . Mechanism of site-specific DNA damage induced by methylhydrazines in the presence of copper(II) or manganese(III). Biochemistry. 1991; 30(12):3069-75. DOI: 10.1021/bi00226a013. View

Patlewicz G, Jeliazkova N, Safford R, Worth A, Aleksiev B . An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ Res. 2008; 19(5-6):495-524. DOI: 10.1080/10629360802083871. View

Hao B, Shen S, Zhao Q . Cytotoxic and antimalarial amaryllidaceae alkaloids from the bulbs of Lycoris radiata. Molecules. 2013; 18(3):2458-68. PMC: 6270500. DOI: 10.3390/molecules18032458. View

Edwards D, Ngwa V, Raybuck A, Wang S, Hwang Y, Kim L . Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2020; 131(4. PMC: 7880417. DOI: 10.1172/JCI140100. View

Grosdidier A, Zoete V, Michielin O . EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins. 2007; 67(4):1010-25. DOI: 10.1002/prot.21367. View

Liu C, Kao C, Wu H, Li W, Huang C, Li H . Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena. Molecules. 2014; 19(11):17829-38. PMC: 6271390. DOI: 10.3390/molecules191117829. View

Law B, Michelangeli F, Qu Y, Xu S, Han Y, Mok S . Neferine induces autophagy-dependent cell death in apoptosis-resistant cancers via ryanodine receptor and Ca-dependent mechanism. Sci Rep. 2019; 9(1):20034. PMC: 6934498. DOI: 10.1038/s41598-019-56675-6. View

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

10.

Jain A . Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des. 1996; 10(5):427-40. DOI: 10.1007/BF00124474. View

11.

Gross M, Demo S, Dennison J, Chen L, Chernov-Rogan T, Goyal B . Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014; 13(4):890-901. DOI: 10.1158/1535-7163.MCT-13-0870. View

12.

Lagunin A, Dubovskaja V, Rudik A, Pogodin P, Druzhilovskiy D, Gloriozova T . CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds. PLoS One. 2018; 13(1):e0191838. PMC: 5784992. DOI: 10.1371/journal.pone.0191838. View

13.

Esslinger C, Cybulski K, Rhoderick J . Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg Med Chem. 2005; 13(4):1111-8. DOI: 10.1016/j.bmc.2004.11.028. View

14.

Saini N, Sterling J, Sakofsky C, Giacobone C, Klimczak L, Burkholder A . Mutation signatures specific to DNA alkylating agents in yeast and cancers. Nucleic Acids Res. 2020; 48(7):3692-3707. PMC: 7144945. DOI: 10.1093/nar/gkaa150. View

15.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

16.

Fritzer-Szekeres M, Grusch M, Luxbacher C, Horvath S, Krupitza G, Elford H . Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells. Exp Hematol. 2000; 28(8):924-30. DOI: 10.1016/s0301-472x(00)00484-7. View

17.

Hanaford A, Alt J, Rais R, Wang S, Kaur H, Thorek D . Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Transl Oncol. 2019; 12(10):1314-1322. PMC: 6657308. DOI: 10.1016/j.tranon.2019.05.013. View

18.

Gill H, Eisenberg D . The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry. 2001; 40(7):1903-12. DOI: 10.1021/bi002438h. View

19.

Ali I, Wani W, Haque A, Saleem K . Glutamic acid and its derivatives: candidates for rational design of anticancer drugs. Future Med Chem. 2013; 5(8):961-78. DOI: 10.4155/fmc.13.62. View

20.

Schneidman-Duhovny D, Inbar Y, Polak V, Shatsky M, Halperin I, Benyamini H . Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins. 2003; 52(1):107-12. DOI: 10.1002/prot.10397. View